Medical Devices Investors & VC Firms in United States

886 firms in this list, with a median first check of $500K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
RO Rockies Venture Adviser, Llc CSDHKKKM6 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
LE Leading Edge Ventures DPMBRBVK5 people	88🔒	Newark	US	Seed–Series A	$50K – $750K	+ Add to CRM
TR Treo Ventures, Llc BHDSMJTP5 people	88🔒	Minneapolis	US	Seed–Late Stage	—	+ Add to CRM
ES Eshelman Ventures, LLC FEAMNH3 people	88🔒	Wilmington	US	Seed–Series A	—	+ Add to CRM
PF PFM Health Sciences CMGLJAVK9 people	88🔒	San Francisco	US	—	—	+ Add to CRM
MO Mountain State Capital MHMGDNNP4 people	88🔒	Morgantown	US	Seed–Series A	$200K – $500K	+ Add to CRM
SU Surface Ventures DBYRBKGK4 people · Leads rounds	88🔒	New York	US	Pre-Seed–Series A	$250K – $2M	+ Add to CRM
TE TEXO Ventures RCPSJDPS4 people	88🔒	Austin	US	Pre-Seed–Series A	—	+ Add to CRM
UP UpStart Ventures DFSBMCSS4 people	88🔒	Salt Lake City	US	Seed–Series A	—	+ Add to CRM
BE Belle Impact Fund CCNPSK3 people · Leads rounds	88🔒	Grosse Pointe Farms	US	Pre-Seed–Series A	$25K – $250K	+ Add to CRM
CO Corner Ventures DKJPMTDK12 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
IN InVivium Capital MLCCALAP6 people	88🔒	Chicago	US	Seed–Late Stage	—	+ Add to CRM
VE Venture Management TFMTDM3 people	88🔒	Madison	US	Seed–Growth	—	+ Add to CRM
HE Healthcare Venture Partners, Llc MYJDASGG8 people	88🔒	Charleston	US	Series B–Late Stage	—	+ Add to CRM
EA East Post Road Ventures FBMSMLRT4 people	88🔒	—	US	Pre-Seed–Series A	—	+ Add to CRM
EC Ecliptic Capital ALMWWHJP4 people · Leads rounds	88🔒	Austin	US	Pre-Seed–Series B	$50K – $5M	+ Add to CRM
GA Galen Partners BWDJDNMH7 people	88🔒	Stamford	US	Growth	—	+ Add to CRM
HB HBS Alumni Angels TLYBYH3 people · Leads rounds	88🔒	Palo Alto	US	Pre-Seed–Series A	$750K – $2M	+ Add to CRM
TA Tachyon Ventures CENDET3 people	88🔒	Los Angeles	US	Pre-Seed–Series A	—	+ Add to CRM
TH The W Fund Follows rounds	88🔒	Seattle	US	Pre-Seed–Series A	$500K	+ Add to CRM
BE Bering Capital EZPSCAGP8 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
FL Fletcher Spaght, Inc. PSBGBSLG8 people	88🔒	Boston	US	Late Stage	—	+ Add to CRM
HO Horizon Technology Finance KJDT2 people	88🔒	Farmington	US	Growth–Late Stage	$3M – $50M	+ Add to CRM

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Rockies Venture Adviser, Llc

DenverPre-Seed–Series A$100K – $500K

CSDHKKKM6 people

Leading Edge Ventures

NewarkSeed–Series A$50K – $750K

DPMBRBVK5 people

Treo Ventures, Llc

MinneapolisSeed–Late Stage

BHDSMJTP5 people

Eshelman Ventures, LLC

WilmingtonSeed–Series A

FEAMNH3 people

PFM Health Sciences

San Francisco

CMGLJAVK9 people

Mountain State Capital

MorgantownSeed–Series A$200K – $500K

MHMGDNNP4 people

Surface Ventures

New YorkPre-Seed–Series A$250K – $2M

DBYRBKGK4 people

TEXO Ventures

AustinPre-Seed–Series A

RCPSJDPS4 people

UpStart Ventures

Salt Lake CitySeed–Series A

DFSBMCSS4 people

Belle Impact Fund

Grosse Pointe FarmsPre-Seed–Series A$25K – $250K

CCNPSK3 people

Corner Ventures

New YorkSeed–Late Stage

DKJPMTDK12 people

InVivium Capital

ChicagoSeed–Late Stage

MLCCALAP6 people

Venture Management

MadisonSeed–Growth

TFMTDM3 people

Healthcare Venture Partners, Llc

CharlestonSeries B–Late Stage

MYJDASGG8 people

East Post Road Ventures

Pre-Seed–Series A

FBMSMLRT4 people

Ecliptic Capital

AustinPre-Seed–Series B$50K – $5M

ALMWWHJP4 people

Galen Partners

StamfordGrowth

BWDJDNMH7 people

HBS Alumni Angels

Palo AltoPre-Seed–Series A$750K – $2M

TLYBYH3 people

Tachyon Ventures

Los AngelesPre-Seed–Series A

CENDET3 people

The W Fund

SeattlePre-Seed–Series A$500K

Bering Capital

San FranciscoSeed–Late Stage

EZPSCAGP8 people

Fletcher Spaght, Inc.

BostonLate Stage

PSBGBSLG8 people

Horizon Technology Finance

FarmingtonGrowth–Late Stage$3M – $50M

KJDT2 people

Data sourced from public filings and firms' own websites — see our methodology.